Marcel M. Verbeek

1994–2024 年に発表

152
論文数
18,467
被引用数
84
h 指数
147
i10 指数

被引用数

Marcel M. Verbeek の年別被引用数1994 年: 被引用 2 件1995 年: 被引用 2 件1996 年: 被引用 6 件1997 年: 被引用 8 件1998 年: 被引用 13 件1999 年: 被引用 13 件2000 年: 被引用 11 件2001 年: 被引用 18 件2002 年: 被引用 12 件2003 年: 被引用 27 件2004 年: 被引用 39 件2005 年: 被引用 35 件2006 年: 被引用 59 件2007 年: 被引用 75 件2008 年: 被引用 72 件2009 年: 被引用 103 件2010 年: 被引用 125 件2011 年: 被引用 157 件2012 年: 被引用 170 件2013 年: 被引用 205 件2014 年: 被引用 263 件2015 年: 被引用 230 件2016 年: 被引用 214 件2017 年: 被引用 221 件2018 年: 被引用 240 件2019 年: 被引用 744 件2020 年: 被引用 870 件2021 年: 被引用 815 件2022 年: 被引用 688 件2023 年: 被引用 524 件2024 年: 被引用 823 件2025 年: 被引用 442 件2026 年: 被引用 10 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,245 件、この内訳の 19.7%イギリス: 引用元論文 1,088 件、この内訳の 9.6%ドイツ: 引用元論文 778 件、この内訳の 6.8%スウェーデン: 引用元論文 698 件、この内訳の 6.1%オランダ: 引用元論文 687 件、この内訳の 6%イタリア: 引用元論文 639 件、この内訳の 5.6%中国: 引用元論文 620 件、この内訳の 5.5%フランス: 引用元論文 421 件、この内訳の 3.7%スペイン: 引用元論文 407 件、この内訳の 3.6%カナダ: 引用元論文 384 件、この内訳の 3.4%オーストラリア: 引用元論文 296 件、この内訳の 2.6%スイス: 引用元論文 288 件、この内訳の 2.5%
0%19.7%その他 24.9%

分野

  • Medicine65.5%
  • Biochemistry, Genetics and Molecular Biology16.8%
  • Neuroscience12.4%
  • Psychology1.6%
  • Immunology and Microbiology1.2%
  • Chemistry0.4%
  • その他2.1%

トピック

  • Alzheimer's disease research and treatments12.7%
  • Dementia and Cognitive Impairment Research7.3%
  • Parkinson's Disease Mechanisms and Treatments4.2%
  • Neuroinflammation and Neurodegeneration Mechanisms2.8%
  • Amyotrophic Lateral Sclerosis Research2.6%
  • Intracerebral and Subarachnoid Hemorrhage Research2.1%
  • その他68.3%

共著者

全論文

検索で開く
  1. Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael Jonsson, Ludwig Kappos, Mohsen Khademi, Michael Khalil, Jens Kühle, Mikael Landén, Ville Leinonen, Giancarlo Logroscino, Ching‐Hua Lu, Jan Lycke, Nadia Magdalinou, Andrea Malaspina, Niklas Mattsson, Lieke Meeter, Sanjay R. Mehta, Signe Modvig, Tomas Olsson, Ross W. Paterson, Josué Pérez‐Santiago, Fredrik Piehl, Yolande A.L. Pijnenburg, Okko T. Pyykkö, Óskar Ragnarsson, Julio C. Rojas, Jeppe Romme Christensen, Linda Sandberg, Carole Scherling, Jonathan M. Schott, Finn Sellebjerg, Isabella Laura Simone, Tobias Skillbäck, Morten Stilund, Peter Sundström, Anders Svenningsson, Rosanna Tortelli, Carla Tortorella, Alessandro Trentini, Maria Troiano, Martin R. Turner, John C. van Swieten, Mattias Vågberg, Marcel M. Verbeek, Luisa María Villar, Pieter Jelle Visser, Anders Wallin, Andreas Weiss, Carsten Wikkelsø, Edward J. Wild - JAMA Neurology 2019 被引用: 760

  2. Prevalence of cerebral amyloid angiopathy: A systematic review and meta‐analysis

    著者: , , , , - Alzheimer s & Dementia 2021 被引用: 306

  3. Effect of 1 Night of Total Sleep Deprivation on Cerebrospinal Fluid β-Amyloid 42 in Healthy Middle-Aged Men

    著者: , , , , , - JAMA Neurology 2014 被引用: 427

  4. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Chemistry and Laboratory Medicine (CCLM) 2021 被引用: 150

  5. Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversion

    著者: , , , , , , , , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2022 被引用: 94

  6. A Practical Guide to Immunoassay Method Validation

    著者: , , , , , , , , , , , , , , , , , , , , - Frontiers in Neurology 2015 被引用: 544

  7. Mechanisms of peripheral levodopa resistance in Parkinson’s disease

    著者: , , - npj Parkinson s Disease 2022 被引用: 113

  8. Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosis

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Neurology 2017 被引用: 214

  9. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gunilla Johansson, Natalia Ermann, John Q. Trojanowski, Ilker Karaca, Holger Wagner, Patrick Oeckl, Linda van Waalwijk van Doorn, Maria Bjerke, Dimitrios Kapogiannis, H. Bea Kuiperij, Lucia Farotti, Yi Li, Brian A. Gordon, Stéphane Epelbaum, Stephanie J. B. Vos, Catharina J.M. Klijn, William E. Van Nostrand, Carolina Minguillón, Matthias Schmitz, Carla Gallo, Andrea Lopez Mato, Florence Thibaut, Simone Lista, Daniel Alcolea, Henrik Zetterberg, Kaj Blennow, Johannes Kornhuber, on Behalf of the Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut - The World Journal of Biological Psychiatry 2017 被引用: 318

  10. Serum NFL discriminates Parkinson disease from atypical parkinsonisms

    著者: , , , , , , , - Neurology 2019 被引用: 153

  11. α‐Synuclein real‐time quaking‐induced conversion in the cerebrospinal fluid of uncertain cases of parkinsonism

    著者: , , , , , - Annals of Neurology 2019 被引用: 145

  12. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ming Lim, G.M.S. Mancini, Adela Della Marina, Loreto Martorell, Joe McMenamin, Marije Meuwissen, Helen Mundy, Nils‐Otto Nilsson, Axel Panzer, Bwee Tien Poll‐The, C. Rauscher, C. M. R. Rouselle, Inger Sandvig, T Scheffner, E. Sheridan, N. B. Simpson, Peter Sýkora, RJ Tomlinson, J Q Trounce, David Webb, Bernhard Weschke, Hans Scheffer, Michèl A.A.P. Willemsen - Brain 2010 被引用: 413

  13. The Personalized Parkinson Project: examining disease progression through broad biomarkers in early Parkinson’s disease

    著者: , , , , , , , , , , , , , , - BMC Neurology 2019 被引用: 123

  14. Cerebrospinal fluid amyloid β40 is decreased in cerebral amyloid angiopathy

    著者: , , , , , - Annals of Neurology 2009 被引用: 205

  15. Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2018 被引用: 113

  16. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury

    著者: , , , , , , , , , - Neurology 2004 被引用: 414

  17. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephan A. Kaeser, Elmar Kaiser, Elisabeth Kapaki, Daniel Kidd, Péter Klivènyi, Cindy Soendersoe Knudsen, Markus P. Kummer, James Lui, Albert Lladó, Piotr Lewczuk, Qiao‐Xin Li, Ralph N. Martins, Colin L. Masters, John C. McAuliffe, Marc Mercken, Abhay Moghekar, José Luís Molinuevo, Thomas J. Montine, William Nowatzke, Richard O’Brien, Markus Otto, George P. Paraskevas, Lucilla Parnetti, Ronald C. Petersen, David Prvulovic, Herman P.M. de Reus, Robert A. Rissman, Elio Scarpini, Alessandro Stefani, Hilkka Soininen, Johannes Schröder, Leslie M. Shaw, Anders Skinningsrud, Brith Skrogstad, Annette Spreer, Leda Leme Talib, Charlotte E. Teunissen, John Q. Trojanowski, Hayrettin Tumani, Robert M. Umek, Bianca Van Broeck, Hugo Vanderstichele, László Vécsei, Marcel M. Verbeek, Manfred Windisch, Jing Zhang, Henrik Zetterberg, Kaj Blennow - Alzheimer s & Dementia 2011 被引用: 412

  18. The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review

    著者: , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2018 被引用: 126

  19. β-Amyloid in CSF

    著者: , , , , , , , , , , , - Neurology 2016 被引用: 82

  20. Decreased Cerebrospinal Fluid Amyloid β 38, 40, 42, and 43 Levels in Sporadic and Hereditary Cerebral Amyloid Angiopathy

    著者: , , , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2023 被引用: 51

  21. The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice

    著者: , , , , , , , , , - Journal of Neurology Neurosurgery & Psychiatry 2017 被引用: 236

  22. Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency

    著者: , , , , , , , , , , , , , , , , , , , - Orphanet Journal of Rare Diseases 2017 被引用: 232

  23. Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oya Kuseyri Hübschmann - Orphanet Journal of Rare Diseases 2020 被引用: 151

  24. Recommendations to Standardize Preanalytical Confounding Factors in Alzheimer’s and Parkinson’s Disease Cerebrospinal Fluid Biomarkers: An Update

    著者: , , , , , , , , , , , , , , , , , , , - Biomarkers in Medicine 2012 被引用: 357